Compare GNLX & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | TYGO |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 207.5M |
| IPO Year | 2023 | N/A |
| Metric | GNLX | TYGO |
|---|---|---|
| Price | $2.92 | $3.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.75 | $6.00 |
| AVG Volume (30 Days) | 355.3K | ★ 1.0M |
| Earning Date | 11-05-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $90,781,000.00 |
| Revenue This Year | N/A | $95.54 |
| Revenue Next Year | N/A | $21.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 97.41 |
| 52 Week Low | $1.99 | $0.58 |
| 52 Week High | $8.54 | $4.50 |
| Indicator | GNLX | TYGO |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 84.66 |
| Support Level | $2.52 | $1.53 |
| Resistance Level | $2.80 | $3.80 |
| Average True Range (ATR) | 0.34 | 0.30 |
| MACD | 0.01 | 0.23 |
| Stochastic Oscillator | 16.17 | 84.44 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.